Dietrich Steinhuebel

Publications

1.3K

Citations

H-Index

1998

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Massachusetts Institute of Technology

MSD (UK) Limited (United Kingdom)

Dietrich Steinhuebel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, engineering, and natural sciences.

Top concepts

BiochemistryChemistryEngineeringNatural SciencesOrganic ChemistryBiomolecular EngineeringMedicinePharmacologyDrug DiscoveryMedicinal Chemistry

Publications per year

1998–2022

Publications

Direct Asymmetric Reductive Amination

Dietrich Steinhuebel, Yongkui Sun, Kazuhiko Matsumura et al. · Journal of the American Chemical Society · 2009 · 210 citations

Engineering, Biochemistry, Natural Sciences +11

First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin

Karl B. Hansen, Jaume Balsells, Spencer D. Dreher et al. · Organic Process Research & Development · 2005 · 158 citations

Dpp-iv Inhibitor Sitagliptin, Medicinal Chemistry, Pharmaceutical Science +14

A kinase-cGAS cascade to synthesize a therapeutic STING activator

John A. McIntosh, Zhijian Liu, Brian M. Andresen et al. · Nature · 2022 · 125 citations

Signal Transduction, Biochemistry, Receptor Tyrosine Kinase +5

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer

Wonsuk Chang, Michael D. Altman, Charles A. Lesburg et al. · Journal of Medicinal Chemistry · 2022 · 122 citations · Full text

Immunology, Molecular Biology, Interferon Genes +17

Stereoselective Enol Tosylation: Preparation of Trisubstituted α,β-Unsaturated Esters

Jenny M. Baxter, Dietrich Steinhuebel, Michael Palucki et al. · Organic Letters · 2004 · 83 citations

Enantioselective Synthesis, Engineering, Biochemistry +12

Rows per page

1–5 of 22